These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8408941)

  • 1. Propofol emulsion reduces proliferative responses of lymphocytes from intensive care patients.
    Pirttikangas CO; Perttilä J; Salo M
    Intensive Care Med; 1993; 19(5):299-302. PubMed ID: 8408941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a lower-lipid propofol emulsion with the standard emulsion for sedation during monitored anesthesia care.
    Song D; Hamza MA; White PF; Byerly SI; Jones SB; Macaluso AD
    Anesthesiology; 2004 May; 100(5):1072-5. PubMed ID: 15114202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of immunoglobulin synthesis in vitro by intravenous lipid emulsion (Intralipid).
    Salo M
    JPEN J Parenter Enteral Nutr; 1990; 14(5):459-62. PubMed ID: 2146415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitogen-activated proliferation of human peripheral lymphocytes in vitro by propionic acid.
    Wajner M; Santos KD; Schlottfeldt JL; Rocha MP; Wannmacher CM
    Clin Sci (Lond); 1999 Jan; 96(1):99-103. PubMed ID: 9857112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emulsion formulation reduces propofol's dose requirements and enhances safety.
    Dutta S; Ebling WF
    Anesthesiology; 1997 Dec; 87(6):1394-405. PubMed ID: 9416725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacodynamic effects of a lower-lipid emulsion of propofol: a comparison with the standard propofol emulsion.
    Song D; Hamza M; White PF; Klein K; Recart A; Khodaparast O
    Anesth Analg; 2004 Mar; 98(3):687-91, table of contents. PubMed ID: 14980920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of in-vitro lymphocyte transformation by the isoquinoline alkaloid berberine.
    Ckless K; Schlottfeldt JL; Pasqual M; Moyna P; Henriques JA; Wajner M
    J Pharm Pharmacol; 1995 Dec; 47(12A):1029-31. PubMed ID: 8932689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the type of parenteral lipids matter? A clinical hint in critical illness.
    Devaud JC; Berger MM; Pannatier A; Sadeghipour F; Voirol P
    Clin Nutr; 2017 Apr; 36(2):491-496. PubMed ID: 26829880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion.
    Kim KM; Choi BM; Park SW; Lee SH; Christensen LV; Zhou J; Yoo BH; Shin HW; Bae KS; Kern SE; Kang SH; Noh GJ
    Anesthesiology; 2007 May; 106(5):924-34. PubMed ID: 17457123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline in mitogen induced proliferation of lymphocytes with increasing age.
    Murasko DM; Weiner P; Kaye D
    Clin Exp Immunol; 1987 Nov; 70(2):440-8. PubMed ID: 3427828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anaesthesia and surgery on the number of and mitogen-induced transformation of T- and B-lymphocytes.
    Salo M
    Ann Clin Res; 1978 Feb; 10(1):1-13. PubMed ID: 354470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of 3-acetyl-deoxynivalenol on the immune response of human peripheral blood lymphocytes.
    Tomar RS; Blakley BR; Schiefer HB; DeCoteau WE
    Int J Immunopharmacol; 1986; 8(2):125-30. PubMed ID: 3710661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of insulin on phytohemagglutinin-P, concanavalin-A, and pokeweed mitogen in diabetic and nondiabetic lymphocytes.
    Glassman AB; Lindsay JH; Bennett CE; Hodges ER
    Ann Clin Lab Sci; 1981; 11(1):9-14. PubMed ID: 7011167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and metabolic tolerance of a concentrated long-chain triglyceride lipid emulsion in critically ill septic and trauma patients.
    García-de-Lorenzo A; López-Martínez J; Planas M; Chacón P; Montejo JC; Bonet A; Ortiz-Leyba C; Sánchez-Segura JM; Ordóñez J; Acosta J; Grau T; Jiménez FJ
    JPEN J Parenter Enteral Nutr; 2003; 27(3):208-15. PubMed ID: 12757115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclophosphamide on in vitro human lymphocyte culture and mitogenic stimulation.
    Sharma BS
    Transplantation; 1983 Feb; 35(2):165-8. PubMed ID: 6600859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equianalgesic doses of subcutaneous but not intrathecal morphine alter phenotypic expression of cell surface markers and mitogen-induced proliferation in rat lymphocytes.
    Hamra JG; Yaksh TL
    Anesthesiology; 1996 Aug; 85(2):355-65. PubMed ID: 8712452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain on injection of lipid-free propofol and propofol emulsion containing medium-chain triglyceride: a comparative study.
    Dubey PK; Kumar A
    Anesth Analg; 2005 Oct; 101(4):1060-1062. PubMed ID: 16192520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclosporin A on the metabolism of unstimulated and mitogen-activated lymphocytes.
    Kay JE; Benzie CR
    Immunology; 1983 May; 49(1):153-60. PubMed ID: 6840802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients.
    Devins SS; Miller A; Herndon BL; O'Toole L; Reisz G
    Crit Care Med; 1992 Dec; 20(12):1644-9. PubMed ID: 1458939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on cognitive function of propofol medium and long chain lipid emulsion in patients with hepatic encephalopathy.
    Yu S; Hu J; Ding L; Yu D
    Panminerva Med; 2017 Dec; 59(4):297-301. PubMed ID: 28884566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.